|
|
Article: Spectrum Pharmaceuticals Reports Fiscal Year 2008 Corporate Update and Pipeline Review
- Article from:
- Wireless News
- Article date:
- April 7, 2009
CopyrightProvided by ProQuest LLC. (Hide copyright information)
|
Wireless News
04-07-2009
Spectrum Pharmaceuticals Reports Fiscal Year 2008 Corporate Update and Pipeline Review
Type: News
Spectrum Pharmaceuticals, Inc.has reported financial results for the fourth quarter and fiscal year ended December 31.
"We achieved a critical milestone in 2008 - the transition from a research and development to a commercial organization," said Rajesh C. Shrotriya, M.D., Chairman, Chief Executive Officer, and President of Spectrum Pharmaceuticals. "Spectrum derives revenues from two FDA- approved, proprietary oncology drugs, has a late stage pipeline of novel products focused primarily on oncology and urology, and has a balanced business strategy involving judicious ...